The Benefits of Flavonoids in Diabetic Retinopathy

被引:45
|
作者
Matos, Ana L. [1 ]
Bruno, Diogo F. [1 ]
Ambrosio, Antonio F. [2 ,3 ,4 ,5 ]
Santos, Paulo F. [1 ,2 ,3 ,4 ]
机构
[1] Univ Coimbra, Dept Life Sci, P-3000456 Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, P-3000548 Coimbra, Portugal
[3] Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, P-3000548 Coimbra, Portugal
[4] Clin Acad Ctr Coimbra CACC, P-3004561 Coimbra, Portugal
[5] Assoc Innovat & Biomed Res Light & Image AIBILI, P-3000548 Coimbra, Portugal
关键词
diabetic retinopathy; flavonoids; neuroprotection; oxidative stress; inflammation; retina; NF-KAPPA-B; NEURONAL CELL-DEATH; BLOOD-RETINAL BARRIER; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; GREEN TEA; IN-VITRO; VASCULAR-PERMEABILITY; PLASMA ABNORMALITIES; ANTIOXIDANT CAPACITY;
D O I
10.3390/nu12103169
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Diabetic retinopathy (DR), one of the most common complications of diabetes, is the leading cause of legal blindness among adults of working age in developed countries. After 20 years of diabetes, almost all patients suffering from type I diabetes mellitus and about 60% of type II diabetics have DR. Several studies have tried to identify drugs and therapies to treat DR though little attention has been given to flavonoids, one type of polyphenols, which can be found in high levels mainly in fruits and vegetables, but also in other foods such as grains, cocoa, green tea or even in red wine. Flavonoids have anti-inflammatory, antioxidant and antiviral effects. Since it is known that diabetes induces oxidative stress and inflammation in the retina leading to neuronal death in the early stages of the disease, the use of these compounds can prove to be beneficial in the prevention or treatment of DR. In this review, we summarize the molecular and cellular effects of flavonoids in the diabetic retina.
引用
收藏
页码:1 / 29
页数:26
相关论文
共 50 条
  • [21] Nuclear proteins and diabetic retinopathy: a review
    Li, Bin
    Hussain, Wahab
    Jiang, Zhi-Liang
    Wang, Jia-Yi
    Hussain, Sarfraz
    Yasoob, Talat Bilal
    Zhai, Yuan-Kun
    Ji, Xin-Ying
    Dang, Ya-Long
    BIOMEDICAL ENGINEERING ONLINE, 2024, 23 (01)
  • [22] Bone morphogenetic protein 2: A potential new player in the pathogenesis of diabetic retinopathy
    Hussein, Khaled A.
    Choksi, Karishma
    Akeel, Sara
    Ahmad, Saif
    Megyerdi, Sylvia
    El-Sherbiny, Mohamed
    Nawaz, Mohamed
    Abu El-Asrar, Ahmed
    Al-Shabrawey, Mohamed
    EXPERIMENTAL EYE RESEARCH, 2014, 125 : 79 - 88
  • [23] NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
    Lim, Rayne R.
    Wieser, Margaret E.
    Ganga, Rama R.
    Barathi, Veluchamy A.
    Lakshminarayanan, Rajamani
    Mohan, Rajiv R.
    Hainsworth, Dean P.
    Chaurasia, Shyam S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [24] Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy
    Sheemar, Abhishek
    Soni, Deepak
    Takkar, Brijesh
    Basu, Soumyava
    Venkatesh, Pradeep
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (11) : 3035 - 3049
  • [25] The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy
    Pang, Baoying
    Zhou, Huanran
    Kuang, Hongyu
    PEPTIDES, 2018, 100 : 123 - 126
  • [26] Proteome changes induced by laser in diabetic retinopathy
    Quin, Godfrey J.
    Lyons, Brian
    Len, Alice C. L.
    Madigan, Michele C.
    Gillies, Mark C.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 (02) : 180 - 187
  • [27] Somatolactogens and diabetic retinopathy
    Bermea, Kevin Christian
    Rodriguez-Garcia, Alejandro
    Tsin, Andrew
    Alberto Barrera-Saldana, Hugo
    GROWTH HORMONE & IGF RESEARCH, 2018, 41 : 42 - 47
  • [28] Inflammation in diabetic retinopathy
    Tang, Johnny
    Kern, Timothy S.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2011, 30 (05) : 343 - 358
  • [29] Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
    Beltramo, Elena
    Porta, Massimo
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (26) : 3218 - 3225
  • [30] Advanced Glycation End Products and Diabetic Retinopathy
    Chen, M.
    Curtis, T. M.
    Stitt, A. W.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (26) : 3234 - 3240